Iambic Therapeutics Statistics
NASDAQ: IAMHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
13.11-1.15 (-8.06%)
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Iambic Therapeutics by the numbers
Iambic Therapeutics has a market capitalization of $621.4 million based on 47.40M shares outstanding. With trailing EPS of $-2.69, Iambic Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.7% below its 50-day average and 9.7% below its 200-day average.
Average daily trading volume is 714.92K shares, or about $9.4 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
IAM valuation vs. peer median
| Metric | IAM | Peer median | Difference |
|---|---|---|---|
| Market cap | $621.42M | $586.77M | +6% |
| Avg. volume | 714.92K | 692.19K | +3% |
Peer median across 8 companies: SRZN, CGEM, FDMT, ENTX, DBVT, ATTO, SLDB, AURA.
Valuation
- Market cap
- $621.42M
- EPS (TTM)
- $-2.69
- Shares outstanding
- 47.40M
Price and trading
- Previous close
- 14.26
- Open
- 13.98
- Day range
- 12.77 – 14.00
- 52-week range
- 9.60 – 25.00
- Beta
- —
- Volume
- 281.91K
- Average volume
- 714.92K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 16, 2026
Additional statistics
- Market Cap
- 621.42M
- Forward Pe
- -4.31
- Eps
- -2.69
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 25.00
- Week52 Low
- 9.60
- Avg Volume
- 714.92K
- Shares Outstanding
- 47.40M
- Ma50
- 14.52
- Ma200
- 14.52
- Earnings Date
- Nov 16, 2026
- Pct From52w High
- -47.56%
- Pct From52w Low
- 36.56%